Trials / Completed
CompletedNCT03437538
Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter
Reduction Ratio and Clearance of Middle Molecules During a Single Hemodialysis Session With Medium Cut-Off (MCO) Filter Compared to Hemodiafiltration (HDF) With Standard High-flux Filter
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Medium Cut-Off dialysis (MCO) membrane has been developed to improve middle molecule removal compared to standard high-flux dialysis filters. The major aim of this study is to compare the reduction ratio of middle molecules, during a single hemodialysis session with MCO-filter, compared to hemodiafiltration (HDF) with standard high-flux filter. Secondary aims are to compare the reduction ratio of small and large molecules between the treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MCO-HD | Measurements will be done during a single hemodialysis session with Medium Cut-Off filter |
| DEVICE | High-flux HDF | Measurements will be done during a single hemodiafiltration session with standard high-flux filter |
Timeline
- Start date
- 2018-05-21
- Primary completion
- 2019-04-16
- Completion
- 2019-04-16
- First posted
- 2018-02-19
- Last updated
- 2019-11-13
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03437538. Inclusion in this directory is not an endorsement.